Imidazolidine Derivatives in Cancer Research: What is known?-Reference-Cited by-同舟云学术

Imidazolidine Derivatives in Cancer Research: What is known?

Published:2021-07-27 Issue: Volume:21 Page:
ISSN:1871-5206
Container-title:Anti-Cancer Agents in Medicinal Chemistry
language:en
Short-container-title:ACAMC

Author:

da Silva Júnior Auvani Antunes¹,da Rocha Pitta Marina Galdino¹,de Oliveira Chagas Mardonny Bruno²,de Melo Rêgo Moacyr Jesus Barreto³,da Rosa Michelle Melgarejo³^ORCID,da Rocha Pitta Maira Galdino³

Affiliation:

1. Federal University of Pernambuco, Recife, Brazil

2. Life Science Center, Federal University of Pernambuco, Caruaru, Brazil

3. Department of Biochemistry, Federal University of Pernambuco, Recife, Brazil

Abstract

: Even though cancer is the second leading cause of death globally, a number of open issues persist in cancer treatment, despite the achievements of the field. This review aims at discussing the fundamental role of Imidazolidine derivatives in the industry of cancer treatment. Compelling data from 1996 to 2021 will introduce Imidazolidine derivatives as a relevant tool to modulate cancer progression.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theoretical investigation of the hydrolysis and DNA binding of platinum (II) complexes of imidazolidine dioximes;Molecular Physics;2023-07-14

2. Structural and Dynamic Behaviour of Heterocycles Derived from Ethylenediamines with Formaldehyde: 1,3,5-Triazinanes and Bis(imidazolidinyl)methanes;Organics;2023-06-15